Compare CRCT & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRCT | AURA |
|---|---|---|
| Founded | 1969 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 913.1M | 797.5M |
| IPO Year | 2021 | 2021 |
| Metric | CRCT | AURA |
|---|---|---|
| Price | $5.56 | $7.71 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $3.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 854.5K | 687.8K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | ★ 22.20% | N/A |
| EPS Growth | ★ 20.69 | N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $708,780,000.00 | N/A |
| Revenue This Year | $0.08 | N/A |
| Revenue Next Year | $0.98 | N/A |
| P/E Ratio | $19.29 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.74 | $4.73 |
| 52 Week High | $6.93 | $9.54 |
| Indicator | CRCT | AURA |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 55.46 |
| Support Level | $4.03 | $6.49 |
| Resistance Level | $6.27 | $9.54 |
| Average True Range (ATR) | 0.33 | 0.48 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 50.65 | 54.41 |
Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.